TerrAscend Corp.
TSX:TSND.TO · Toronto Stock Exchange
-$0.02 today
Vol 0.12M · Avg 0.31M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-90.2%
avg -1236.9%
ROIC
-44.2%
avg -2.9%
ROA
-15.5%
avg -31.3%
Analysis
ROA is currently the strongest return metric at -15.5% versus its period average of -31.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Ziad Ghanem | President & Chief Executive Officer | $1.49M | — | 48 | — | — |
Lynn Gefen | Chief People Officer, Chief Legal Officer & Corporate Secretary | $954,396.00 | — | 54 | — | — |
Eric Jackson | Chief Financial Officer | $946,049.00 | — | — | — | — |
Jason Garrett Wild | Executive Chairman | $569,467.00 | — | 53 | — | — |
Carretta | Senior Vice President of Marketing | — | — | — | — | — |
David Wheeler | Senior Vice President & Chief Information Officer | — | — | — | — | — |
Alisa Campbell | Senior Vice President of Corporate Finance & Accounting | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +38.1% (12yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +38.1% (12yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
Cipher Pharmaceuticals Inc.
TSX:CPH.TO
$408.55M
Fennec Pharmaceuticals Inc.
TSX:FRX.TO
$360.97M
Eupraxia Pharmaceuticals Inc.
TSX:EPRX.TO
$325.95M
Medical Facilities Corporation
TSX:DR.TO
$315.55M
Auxly Cannabis Group Inc.
TSX:XLY.TO
$250.54M
Canopy Growth Corporation
TSX:WEED.TO
$245.35M
Aurora Cannabis Inc.
TSX:ACB.TO
$235.34M
OrganiGram Holdings Inc.
TSX:OGI.TO
$188.33M
HLS Therapeutics Inc.
TSX:HLS.TO
$133.86M
Jushi Holdings Inc.
JUSH.CN
$133.80M
Who manages TSND.TO?
TerrAscend Corp. (TSND.TO) lists 7 active executives. The top listed executive is Carretta, Senior Vice President of Marketing.
Explore More
Continue the stock analysis
Jump to another research area for this company.